The bone marrow transplantation market is set growth at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2022 to 2030. According to the research findings provided by Bristol-Myers Squibb Company, by 2040 there will be 1.85 million new cases of blood cancer will be reported worldwide.
The antimicrobial susceptibility test market had market size of US$ 2885.42 Mn in 2021 and will grow at a CAGR 4.7% and is anticipated to reach US$ 4354.68 Mn in 2030. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics. Rising prevalence of infectious disease and looming threat of superbug infection drives the antimicrobial susceptibility market growth.
Phospholipase enzyme market is projected to reach US$ 617.4 Mn by 2030 with 7.0% CAGR during the forecast period from 2022 to 2030. In 2021, North America held the largest value share in the global phospholipase enzyme market. Asia Pacific is projected to be the fastest-growing region between 2022 and 2030.
Immunization of livestock has been carried out worldwide for centuries and is also accepted as a cost effective measure of controlling infections. Until recently, vaccines were either live attenuated or inactivated organisms formulated with oil-based adjuvant; however these methods and formulations were not very effective.
Aptamers are chemically synthesized peptides or oligonucleotide molecules that bind to a specific target nucleic acid, protein, or lipid. Aptamers are used in various fields such as drug delivery, diagnostics, and therapeutics.
Cell isolation & separation is the process of separating individual living cells from another within a biological sample such as blood or tissue. Cell isolation & separation techniques comprise centrifugation, FACS (fluorescence-activated cell sorting), BACS (buoyancy-activated cell sorting), MACS (magnetic-activated cell sorting), and microfluidics or filtration.
Cell cultures are an important and fundamental tool essential for the development of target based therapies such as biosimilars, biologics and personalized medicine. The current trend for developing medication is making it more patient centric thus personalized medicines are in greater demand for treating various chronic conditions and orphan indications. The development of target based therapies for the above-mentioned conditions require to be carried at a faster pace with no scope for errors during the development stages.
Biometrics in healthcare applications essentially refer to staff and patient identification solutions. Biometrics solutions are often used in combination with smart cards and passwords for secure access to sensitive records and reports, and to facilitate patient registration requirements. In the near future biometrics use in healthcare will reflect the growing demand to address healthcare frauds in the developed markets along with the escalating need to ensure patient privacy.
The biological safety testing market is set to reach US$ 8,935.4 Mn by 2026 from US$ 3,120.8 Mn in 2017 growing at an impressive pace with a compounded annual growth rate (CAGR) of 12.5% during the forecast period from 2018 to 2026. The primary features responsible for the biological safety testing market are rising prevalence of chronic diseases and rapid growth in the clinical laboratories worldwide.
Global Stem Cells Market by Products (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells and Very Small Embryonic Like Stem Cells) by Applications (Regenerative Medicine, Drug Discovery and Development) by Therapy (Autologous Stem Cells Therapy, Allogenic Stem Cells Therapy) - Market Growth, Future Prospects & Competitive Analysis, 2017 – 2025
Biopharmaceutical Market Research Reports
Biopharmaceutical is termed as a drug that is manufactured by biotechnological means. It is a therapeutic agent aimed at treating various kinds of disease symptoms, diseases and disorders of the body. Biopharmaceutical is a drug not produced due to any chemical reaction nor through any synthesized biological source. But it is produced through use of living organisms like bacteria, yeast, stem cells or mammalian cells which may have been altered to generate the required compound. Biopharmaceutical is available in the form of RNA protein, DNA protein and nucleic acid in nature. It is used for healing purpose and in vivo diagnostic process.
The initial biopharmaceutical drug introduced for therapeutic use in the medical field was artificial human insulin. This drug was released in year 1982 to utilize it in treatment of diabetic patients all over the globe.
Biopharmaceutical drug has been effective in treating the most inflexible medical conditions like cancer ailment and autoimmune disease. It is manufactured by using certain distinctive method whose research cost and cost of production is very high. Due to this, these drug is placed among the high cost lists of drug prescriptions.
As per the biotechnology market, over four hundred biopharmaceutical items are used in treatment of two hundred ailments in medical experimental phases, some of whom for which no medical treatment is available till date. Since last few years, Food and Drug Administration (FDA), a regulatory body based in USA which regulates the use of drugs all over the world, has approved biopharmaceutical items for treating different kinds of medical ailments arising due to various medical conditions. As a result, the export flow of the biopharmaceutical drugs has almost doubled from a figure of thirty five billion US dollars to seventy three billion US dollars. Today, the biopharmaceutical market is flourishing in terms of market revenue, exploration, advances, benefits, advantages, biotechnological breakthroughs and medical as well as scientific achievements.
You can search for the related information about the biopharmaceuticals drugs and products on our web portal displaying biopharmaceutical market research reports.
